NCT05370287View on ClinicalTrials.gov

Adaptive Optics Retinal Imaging

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Glaucoma, Primary Open Angle
Interventions
OTHER

oxygen inhalation

Subjects will breath 100% oxygen through a mask.

DEVICE

Adaptive optics imaging

Adaptive optics scanning laser ophthalmoscopy (AOSLO) and adaptive optics - optical coherence tomography (AO-OCT) retinal imaging

Trial Locations (1)

20993

RECRUITING

Food and Drug Administration, Silver Spring

All Listed Sponsors
collaborator

University of Maryland, Baltimore

OTHER

lead

Food and Drug Administration (FDA)

FED